In mice lacking adaptive immunity (RAG-deficient), the innate compartment of the gut-draining mesenteric lymph nodes and colon drifts into a type 1 inflammatory state: innate lymphoid cells (ILCs) over-produce interferon-γ (IFN-γ), diversify abnormally, monocytes adopt inflammatory trajectories, and colonic epithelial cells express altered antimicrobial peptides and lose Paneth-like features. Restoring adaptive immunity, depleting ILCs, or abolishing IFN-γ signaling reduces these changes, with loss of IFN-γ signaling producing only a partial reversal, establishing that adaptive immune cells normally act as a homeostatic brake on type 1 innate polarization — but the molecular and cellular mechanisms of this brake are unknown. The open problem is to identify those mechanisms: whether they are purely cell-extrinsic or also involve RAG gene expression intrinsic to innate lymphocytes; which cytokines besides IFN-γ — including the roles of type I and type III interferons — drive the residual type 1 bias; and whether specific commensals (such as segmented filamentous bacteria or Akkermansia muciniphila) causatively drive ILC-derived IFN-γ and the associated antimicrobial-peptide and microbiota changes.

Background

Innate lymphoid cells (ILCs) are lymphocyte-lineage, tissue-resident immune cells that lack rearranged antigen receptors (the defining feature distinguishing them from T and B cells) and respond rapidly to cytokine and epithelial signals. Group 1 ILCs comprise natural killer (NK) cells and ILC1s, which produce interferon-γ (IFN-γ), the signature cytokine of type 1 immunity. ILCs develop from the same common lymphoid progenitor (the early bone-marrow precursor of all lymphocytes) as T and B cells, and the V(D)J recombinase genes RAG1 and RAG2 — required to assemble antigen receptors in T and B cells — are transiently expressed during ILC development, raising the question of whether RAG expression leaves an intrinsic imprint on ILC function, independent of its role in generating adaptive lymphocytes. 'Tonic' IFN-γ denotes low-level, steady-state IFN-γ production in the absence of infection; ILC1-derived tonic IFN-γ was shown to maintain antiviral readiness in the oral mucosal epithelium (Shannon et al., Immunity 2021), so tonic type 1 signaling is physiologically meaningful, not noise. In infection, memory T cell-derived IFN-γ instructs innate cell activation (Soudja et al., Immunity 2014), and RAG-deficient (RAG2KO) mice — which lack mature T and B cells — are the standard model of adaptive-immune deficiency. Single-cell profiling of RAG2KO mice by Mejri et al. (bioRxiv 2024) revealed that, even at steady state, innate cell interactions in the mesenteric lymph nodes (the lymph nodes draining the intestine) become dominated by an IFN-γ signaling network: ILCs acquire myeloid markers (markers normally restricted to monocyte/macrophage lineages), monocytes adopt an inflammatory path, and colonic epithelial cells show altered antimicrobial peptides (AMPs, secreted peptides with direct microbicidal activity) and lose Paneth-like features (Paneth cells are specialized epithelial cells secreting AMPs). Depleting ILCs, deleting IFN-γ receptor signaling (e.g., in RAG2KO × IFNγR double-knockout mice, where the rescue is only partial), or restoring adaptive immunity reduces these changes, and the microbiota of RAG2KO mice is itself altered, with candidate commensal drivers such as segmented filamentous bacteria (SFB, a mouse intestinal commensal that potently induces Th17 cells — a pro-inflammatory CD4+ T-helper subset — and ILC responses) and Akkermansia muciniphila (a mucin-colonizing bacterium). The preprint's authors therefore conclude that adaptive immunity tonically silences ILC-derived IFN-γ and restrains type 1 innate polarization during homeostasis, while stating that the exact molecular and cellular mechanisms remain incompletely elucidated.

Problem Statement

Identify the molecular and cellular mechanisms by which adaptive immune cells (T and B cells) restrain type 1 polarization and diversification of innate lymphoid cells, and the consequent IFN-γ-driven remodeling of monocytes and intestinal epithelium, at steady state. This single objective comprises the source's linked mechanistic questions, each of which pins a different facet of the same homeostatic regulatory circuit: (1) whether the restraint is purely cell-extrinsic (mediated by adaptive lymphocytes and their products) or also reflects a cell-intrinsic effect of RAG gene expression history in innate lymphocytes; (2) which cytokines, in addition to IFN-γ, drive the residual type 1-biased signature indicated by the only partial rescue in RAG2KO mice lacking IFN-γ receptor — including the roles of type I and type III interferons in this homeostatic context; (3) the microbial mechanism underlying the altered antimicrobial-peptide expression and microbiota composition, i.e., whether specific commensals (such as segmented filamentous bacteria or Akkermansia muciniphila) causatively drive ILC IFN-γ production, as testable with germ-free (raised without microorganisms) and gnotobiotic (colonized only with defined microbial species) mouse models. All three facets — the extrinsic-versus-intrinsic distinction, the IFN-γ-versus-other-cytokine distinction, and the microbial mechanism — are described by Mejri et al. as unresolved facets of this mechanistic question, and a mechanistic account of the cells, receptors, cytokines, and microbes involved would need to address all three in order to explain the phenomenon they established. The interferons and commensals named above are the source's candidate drivers rather than a closed list, so an account may identify additional cytokines or commensals where the evidence supports them.

References

  1. Mejri O, Ma L, Aoudi A, Labiad O, Mondot S, Igalouzene R, Codan C, Hernandez-Vargas H, Rousseaux N, Lapaque N, Paul S, Walzer T, Marie JC, Soudja S. Adaptive immunity shapes innate and epithelial cell landscapes by silencing tonic IFN-γ in innate lymphoid cells during homeostasis. bioRxiv preprint posted 2024-09-22. DOI: 10.1101/2024.09.19.613869. https://doi.org/10.1101/2024.09.19.613869
  2. Ver Heul AM, Mack M, Zamidar L, Tamari M, Yang TL, Trier AM, Kim DH, Janzen-Meza H, Van Dyken SJ, Hsieh CS, Karo JM, Sun JC, Kim BS. RAG suppresses group 2 innate lymphoid cells. eLife, 2025;13:RP98287. DOI: 10.7554/eLife.98287. https://doi.org/10.7554/eLife.98287
  3. Sprissler J, Pannicke U, Rump EM, Schrezenmeier H, Casadei N, Pogoda M, Kuhlburger L, Oquendo MB, Czemmel S, Debatin KM, Erlacher M, Schwarz K, Felgentreff K. RAG recombinase expression discriminates the development of natural killer cells. Frontiers in Immunology, 2025;16:1607664. DOI: 10.3389/fimmu.2025.1607664. https://doi.org/10.3389/fimmu.2025.1607664
  4. Shannon JP, Vrba SM, Reynoso GV, Wynne-Jones E, Kamenyeva O, Malo CS, Cherry CR, McManus DT, Hickman HD. Group 1 innate lymphoid-cell-derived interferon-γ maintains anti-viral vigilance in the mucosal epithelium. Immunity, 2021;54(2):276-290.e5. DOI: 10.1016/j.immuni.2020.12.004. https://doi.org/10.1016/j.immuni.2020.12.004
  5. Soudja SM, Chandrabos C, Yakob E, Veenstra M, Palliser D, Lauvau G. Memory-T-cell-derived interferon-γ instructs potent innate cell activation for protective immunity. Immunity, 2014;40(6):974-988. DOI: 10.1016/j.immuni.2014.05.005. https://doi.org/10.1016/j.immuni.2014.05.005
  6. Dobeš J, Brabec T. Dietary influence and immune balance: Regulating CD4+ IEL responses and MHCII in the gut. Mucosal Immunology, 2025;18(1):36-38. DOI: 10.1016/j.mucimm.2024.12.011. https://doi.org/10.1016/j.mucimm.2024.12.011
  7. Aliyu M, Saboor-Yaraghi AA, Sahraian MA, Noorbakhsh F, Adamu AY, Sharif AA, Abdulqadir Z. Innate lymphoid cells: unsung heroes or villains in multiple sclerosis pathogenesis? Immunologic Research, 2026;74(1):13. DOI: 10.1007/s12026-025-09734-2. https://doi.org/10.1007/s12026-025-09734-2